Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa
Open Access
- 31 October 2006
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 95 (11) , 1525-1528
- https://doi.org/10.1038/sj.bjc.6603441
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Targeted therapy in colorectal cancer: do we know enough?Digestive and Liver Disease, 2006
- Assessing epidermal growth factor receptor expression in tumours: What is the value of current test methods?European Journal Of Cancer, 2005
- Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by ImmunohistochemistryJournal of Clinical Oncology, 2005
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesisProceedings of the National Academy of Sciences, 2002
- Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinomaCancer, 2001
- Epidermal growth factor-related peptides and their receptors in human malignanciesPublished by Elsevier ,2000
- Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2Human Pathology, 1998
- Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.1997
- EPIDERMAL GROWTH-FACTOR RECEPTORS IN COLORECTAL-CARCINOMA1990